Novo Nordisk News
Most Popular Novo Nordisk Story
Novo Nordisk reports positive data in diabetes trials
Denmark's Novo Nordisk has seen its shares surge on the news that Liraglutide has produced positive results in two late-stage trials, positioning it for regulatory approval next year. The two Phase... Read more...
Latest Headlines
- October 17, 2008
- September 28, 2008
- September 8, 2008
- August 6, 2008
- July 29, 2008
- March 19, 2008
- March 11, 2008
- January 15, 2008
- October 25, 2007
- October 17, 2007
- September 21, 2007
- September 17, 2007
- September 5, 2007
- August 20, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
